ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Yoshiki Sawa
Toshiki Takahashi
Goro Matsumiya
Yuji Miyamoto
Hikaru Matsuda
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shintani, T.
Right arrow Articles by Matsuda, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shintani, T.
Right arrow Articles by Matsuda, H.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2002;74:1132-1137
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Intraoperative transfection of vein grafts with the NF{kappa}B decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia

Takuji Shintani, MDa, Yoshiki Sawa, MDa, Toshiki Takahashi, MDa, Goro Matsumiya, MDa, Nariaki Matsuura, MDb, Yuji Miyamoto, MDa, Hikaru Matsuda, MDa*

a Department of Surgery, Course of Interventional Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
b Department of Pathology, School of Allied Sciences, Faculty of Medicine, Osaka University, Osaka, Japan

Accepted for publication June 17, 2002.

* Address reprint requests to Dr Matsuda, Department of Surgery, Course of Interventional Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
e-mail: matsuda{at}surg1.med.osaka-u.ac.jp

BACKGROUND: The nuclear transcriptional factor NF{kappa}B is reported to play an important role in the expression of genes for neutrophil and macrophage chemotactic factors, adhesion molecules, and cell cycle–regulating proteins. In aortocoronary bypass surgery, the saphenous vein often develops vein graft disease. Here, we investigated whether transfection of a cis element decoy oligodeoxynucleotide of NF{kappa}B (NF{kappa}B decoy) into the vein graft wall suppresses neointimal hyperplasia and the differentiation of medial smooth muscle cells.

METHODS: We established a canine aortocoronary bypass grafting model that has a saphenous vein graft between the left anterior descending coronary artery and the descending aorta. Pressure-mediated transfection of a scrambled (SD group; n = 5) or NF{kappa}B decoy (ND group; n = 5) into the graft wall was performed intraoperatively. The grafts were gently harvested at 4 weeks postoperative, and the middle portion of the graft was examined histopathologically.

RESULTS: The average neointimal area of the ND group was significantly suppressed (SD group, 2.63 ± 1.00 mm2 vs ND group, 0.88 ± 0.66, p < 0.05), and the differentiation and proliferation of the medial smooth muscle cells in the ND group were also suppressed (proliferating cell nuclear antigen index: SD group, 56 ± 24 vs ND, 13 ± 4, p < 0.05).

CONCLUSIONS: These results demonstrated the efficacy of intraoperative transfection of the NF{kappa}B decoy into the vein graft wall for attenuation of neointima formation.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Xing, W. Feng, L. G. Not, A. P. Miller, Y. Zhang, Y.-F. Chen, E. Majid-Hassan, J. C. Chatham, and S. Oparil
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H335 - H342.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Hinokiyama, G. Valen, S. Tokuno, J. B. Vedin, and J. Vaage
Vein graft harvesting induces inflammation and impairs vessel reactivity.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1458 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Schachner, G. Laufer, and J. Bonatti
In vivo (animal) models of vein graft disease.
Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 451 - 463.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Lehoux
Redox signalling in vascular responses to shear and stretch
Cardiovasc Res, July 15, 2006; 71(2): 269 - 279.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Schachner
Pharmacologic inhibition of vein graft neointimal hyperplasia
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1065 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
M. J. MANN
Transcription Factor Decoys: A New Model for Disease Intervention
Ann. N.Y. Acad. Sci., November 1, 2005; 1058(1): 128 - 139.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Ohmori, S.-i. Takeda, S. Miyoshi, M. Minami, S. Nakane, M. Ohta, Y. Sawa, and H. Matsuda
Attenuation of lung injury in allograft rejection using NF-{kappa}B decoy transfection--novel strategy for use in lung transplantation
Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 23 - 27.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.